3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
16
Medulloblastoma
5
Glioma
5
Brain Neoplasms
5
Neoplasms
3
Recurrence
2
Oligodendroglioma
2
Central Nervous System Neoplasms
2
Sarcoma
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Kidney Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Gliosarcoma
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Bone Neoplasms
1
Astrocytoma
1
Interventions
Methylprednisolone
3
Social Determinants of Health
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
pegaspargase
1
Vincristine
1
Temozolomide
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Pharmaceutical Services
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Irinotecan
1
Infliximab
1
Hydrocortisone
1
Fecal Microbiota Transplantation
1
Etoposide
1
Drug Therapy
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Cytarabine
1
Cyclophosphamide
1
Cefixime
1
CTLA-4 Antigen
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
Lomustine
×
1 year
×
Clear all
No trials found.